Review on ocular inserts

International Journal of PharmTech Research

Volumn 1, Issue 2, 2009, Pages 164-169

  Rathore, K S ^a   Nema, R K ^b  

^a BN College of Pharmacy   (India)

^b SDCollege of Pharmacy   (India)

Author keywords

In situ gel; Newer ocular drug delivery system; Ocular inserts

Indexed keywords

EID: 77953419870     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Katz, I. M., Shaped ophthalmic inserts for treating dry eyes syndrome. U.S. Patent. 1982; 4,343,787.
2. Cohen, E.M., Grim, W.M., Harwood, R.J., and Mehta, G.N., "Solid state ophthalmic medication, U.S. Patent, 1979; 4:, 179,597.
3. Bawa, R., "Ocular inserts, In: Ophathalmic drug delivery systems, Marcel Dekker, Inc., New York (Mitra. A.K edr), 1993; 58:223.
4. Chrai, S.S., and Robinson, J.R., "Ocular evaluation of methyl cellulose vehicle in albino rabbits". J. Pharm. Sci., 1974; 63: 1218.
5. Chrai, S.S., Makoid, M.C., Erikson, S.P., and Robinson, J.R., "Drop size and initial dosing frequency problems of topically applied ophthalmic drugs". J. Pharm. Sci., 1974; 64; 333.
6. Zaki, I., Fitzgerald, P., Hardy, J.G., and Wilson, C.G., "Comparison of effect of viscosity on the precorneal residence of solution in rabbit and man". J.Pharm. Pharmacol, 1986; 38: 463.
7. Lee, V.H.L., and Robinson, J.F., "Review: Topical ocular drug delivery; recent developments and future challenges". J. Ocul. Pharmacol., 1976; 2: 67.
8. Saettone, M.F., and Salminen, L., "Ocular inserts for topical delivery". Advanced drug delivery reviews, 1995; 16(1): 95.
9. Schoenwald, R.D., "Ocular Pharmacokinetics/Pharmacodynamics chapter-4, In: Ophthalmic Drug Delivery Systems, Vol- 58, Marcel Dekker, Inc., New York. 1993; 83-103.
10. Davis, J. L., Gilger, B.C., Robinson, M.R. Novel approaches to ocular drug delivery. Curr Opin Mol ther.2004 Apr; 6(2):195-205.
11. Sklubalova, Z., "In-situ gelling polymer for ophthalmic drops" Ceska Slov Farm.2005 Jan;54(1):4-10.
12. Jibry, N., Heenan R.K., Murdan, S. Amphiphilogels for drug delivery. Pharm Res.2004 Oct; 21(10):1852-1861
13. Mainardes, R. M., Urban, M.C., Cinto, P.O., Chaud, M.V. Colloidal carriers for ophthalmic drug delivery. Curr drug targets.2005 May; 6(3): 363-371
14. Neefe, C. W., "Contact lens for ocular drug delivery", U.S. Patent, 1974; 3,786,812.
15. nd edition, Marcel Dekker, New York, 1993; 145.
16. Robinson, J.C., "Ocular Anatomy and Physiology Relevant to Ocular Drug Delivery Chapter - 2, In: Ophthalmic drug delivery systems. Vol- 58, Marcel Dekker, New York, 1993: 29.
17. th edition, Medical allied Agency, Calcutta, 1994, 2.
18. Zaffaroni, A, Michaelsw, A.S., and Theeuwes, F., "Osmotic releasing device having a plurality of release rate patterns", U.S. Patent, 1977; 4,036,227.
19. Chrai, S.S., Patton, T.F., Mehta, A., and Robinson, J.R., "Lachrymal and instilled fluid dynamics in rabbit's eyes". J. Pharm. Sci., 1973; 62:1112.
20. Friedrich, S., W., Saville, B.A., Cheng, Y.L., Rootman, D.S. Pharmacokinetic differences between ocular inserts and eyedrops. J Ocul Pharmacol Ther.1996 spring; 12(1):5-18. (Pubitemid 26068312)
21. Michaels, A. S., and Guilloid, M.S., "Osmotic bursting drug delivery device", U.s. Patent; 1979; 4,177,256.
22. Hughes, P.M., and Mitra, A.K, Overview of ocular drug delivery and Iatrogenic ocular cytopathologies, In: Ophthalmic Drug Delivery Systems, Marcel Dekker, Inc., New York, 1993, 58:2.
23. Di Colo, G., Burgalassi S., Chetoni,P. "Gel forming ocular inserts for ocular controlled delivery", Int.J.Pharm.,2001Mar 14;215(1-2):101-111
24. Shell, J.W., and Gale, R.M., "Topical composition containing steroidal in two forms released independently from polymeric carrier", U.S. Patent. 1984; 4, 432,964.
25. Gurtler, F., and Gurny, R., 'Patent literature review of ophthalmic inserts". Drug Dev. Ind. Pharm., 1995; 21(1):1.
26. Bloomfield, S.E., Miyata, T., Dunn, M.W., et al., "Soluble gentamacin ophthalmic inserts as a delivery system ". Arch Opthalmol. 1978; 96:885. (Pubitemid 8314569)
27. Ahmed, I., Gokhale, R.D., et al., "Physicochemical determinants of drug diffusion across the conjunctiva, sclera and cornea". J. Pharm. Sci., 1987; 76: 583. (Pubitemid 18026341)
28. Elter, M.G., Schoenwald, R.D., et al., "Optimization models for corneal penetration of ethoxyzolamide analogues". J. Pharm. Sci., 1985; 74: 155.
29. Huang, H.S., Schoenwald, R.D., and Lach, J.L., "Corneal penetration behavior of b blocking agents II" J. Pharm. Sci., 1983; 72:1272.
30. Grass, G.M., and Robinson, J.R., "Mechanisms of corneal drug penetration II: Ultra structural analysis of potential pathways for drug movements". J. Pharm. Sci., 1988; 77:15.
31. Alvarez-Lorenzo, C., Hiratani, H. Soft contact lenses capable of sustained delivery of timolol. J.Pharm. Sc. 2002Oct; 91(10):2182-2192
32. Patton, T. F., and Robinson, J.R., "Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eye". J. Pharm. Sci., 1976; 65: 1295.
33. Himmelstein, K.J., Guvenir, I., and Palton, T.P., "Preliminary Pharmacokinetics model of pilocarpine uptake and distribution in the eye". J. Pharm. Sci., 1978; 67: 603. (Pubitemid 8364954)
34. Mitra, A. K., "Ophthalmic drug delivery, In: Drug Delivery Devices. (Tyle, P., edr), Marcel Dekker, Inc, New York, 1998: 455.
35. Chrai, S.S., Makoid, M.C., Erikson, S.P., and Robinson, J.R., "Drop size and initial dosing frequency problems of topically applied ophthalmic drugs". J. Pharm. Sci., 1974; 64; 333.
36. Di Colo, G., Zambito,Y. A study of release mechanism of different ophthalmic drug from erodible ocular inserts based on poly (ethylene oxide), Eur J Pharm Biopharm.2002 Sep; 54(2):193-199
37. Seig, J.W., and Robinson, J.R., "Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine". J. Pharm. Sci., 1977; 66: 1222.
38. Keister, J.C. et al. "Limited on optimizing ocular drug delivery". J. Pharm. Sci., 1991; 80(1): 50.
39. De, T.K., Rodman, D.J., Holm, B.A., Prasad, P.N. Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery. J Microencapsul.2003 May-Jun; 20(3):361-374